<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Yonsei Med J</journal-id>
      <journal-id journal-id-type="publisher-id">YMJ</journal-id>
      <journal-title-group>
        <journal-title>Yonsei Medical Journal</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0513-5796</issn>
      <issn pub-type="epub">1976-2437</issn>
      <publisher>
        <publisher-name>Yonsei University College of Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">18972609</article-id>
      <article-id pub-id-type="pmc">2615377</article-id>
      <article-id pub-id-type="doi">10.3349/ymj.2008.49.5.857</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Rescue Treatment with Intra-arterial Tirofiban Infusion and Emergent Carotid Stenting</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Song</surname>
            <given-names>Tae Jin</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Kee Oog</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Dong Joon</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Lee</surname>
            <given-names>Kyung-Yul</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Diagnostic Radiology, Yonsei University College of Medicine, Seoul, Korea.</aff>
      <author-notes>
        <corresp>
Reprint address: requests to Dr. Kyung-Yul Lee, Department of Neurology, Yongdong Severance Hospital, Yonsei University College of Medicine, 612 Eonjuro, Gangnam-gu, Seoul 135-720, Korea. Tel: 82-2-2019-3325, Fax: 82-2-3462-5904, <email>kylee@yuhs.ac</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>31</day>
        <month>10</month>
        <year>2008</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>31</day>
        <month>10</month>
        <year>2008</year>
      </pub-date>
      <volume>49</volume>
      <issue>5</issue>
      <fpage>857</fpage>
      <lpage>859</lpage>
      <history>
        <date date-type="received">
          <day>22</day>
          <month>3</month>
          <year>2007</year>
        </date>
        <date date-type="accepted">
          <day>08</day>
          <month>5</month>
          <year>2007</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2008 The Yonsei University College of Medicine</copyright-statement>
        <copyright-year>2008</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Rapid arterial rethrombosis is associated with high-grade residual stenosis and usually occurs at the site of the initial occlusion, resulting in reocclusion of the recanalized artery. Platelets may play an active role in such rethrombosis after thrombolytic-induced clot lysis. Given that glycoprotein IIb/IIIa receptor blockers, like tirofiban, prevent thrombus formation by inhibiting the final common pathway of platelet aggregation, they may be helpful for treating rethrombosis after thrombolysis. A 64-year-old man presented with an acute ischemic stroke due to internal carotid artery (ICA) occlusion. The ICA was recanalized by intravenous thrombolysis but reoccluded shortly after recanalization. The reoccluded ICA was successfully recanalized using intra-arterial tirofiban. A carotid stent was subsequently inserted to relieve severe stenosis and to prevent recurrent stroke. Here, we report a case of rescue treatment of a successfully recanalized ICA by intra-arterial tirofiban. We suggest that rescue use of intra-arterial tirofiban may be effective and safe, especially in hemorrhage prone situations, due to the relatively lower dose of tirofiban compared with intravenous doses.</p>
      </abstract>
      <kwd-group>
        <kwd>Carotid stent</kwd>
        <kwd>glycoprotein IIb/IIIa receptor blocker</kwd>
        <kwd>tissue plasminogen activator</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Reocclusion after successful arterial recanalization occurs commonly in acute ischemic stroke.<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref> Rapid rethrombosis is associated with high-grade residual stenosis and usually occurs at the site of the initial occlusion, resulting in reocclusion of the recanalized artery.<xref ref-type="bibr" rid="B3">3</xref> Platelets may play an active role in such rethrombosis following thrombolytic-induced clot lysis.</p>
      <p>Glycoprotein (GP) IIb/IIIa receptor blockers prevent thrombus formation by inhibiting the final common pathway of platelet aggregation. There are three GP IIb/IIIa receptor blockers (abciximab, tirofiban, eptifibatide) available for clinical use. There are significant differences in the biological and plasma half-lives of abciximab and the small molecule agents (tirofiban and eptifibatide). Tirofiban is a small, non-peptide molecule that has been used intravenously, in combination with recombinant tissue plasminogen activator (rt-PA), to treat patients with acute coronary artery disease. Some promising pilot results using intravenous tirofiban combined with thrombolytics for acute ischemic stroke have been demonstrated.<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref></p>
    </sec>
    <sec sec-type="cases">
      <title>CASE REPORT</title>
      <p>A 64-year-old man was admitted to the hospital due to left-sided weakness and drowsiness. His initial National Institutes of Health Stroke Scale (NIHSS) score was 16. Brain CT showed no low-density lesions, but bilateral cervical internal carotid artery (ICA) occlusions were observed on CT angiography (<xref ref-type="fig" rid="F1">Fig. 1</xref>). Intravenous rt-PA was administered 160 minutes after the initial onset of symptoms. Because there was no improvement at the end of the intravenous rt-PA infusion, we proceeded to cerebral angiography to perform intra-arterial thrombolysis. Cerebral angiography showed complete occlusion of the left cervical ICA and severe stenosis of the right cervical ICA (<xref ref-type="fig" rid="F2">Fig. 2A</xref>) with delayed filling of the right middle cerebral artery and both anterior cerebral arteries. The left ICA territory was supplied by an ophthalmic collateral from the left external carotid artery and pial collateral flow from the left posterior cerebral artery. Due to the severe stenosis of the right ICA and delayed intracranial perfusion, plans were made to insert a carotid stent to prevent recurrent ischemic stroke. However, the right ICA was reoccluded approximately 20 minutes after the initial angiography (<xref ref-type="fig" rid="F2">Fig. 2B</xref>). Tirofiban was administered through the microcatheter by hand injection. After injection of 200 &#xB5;g of tirofiban over five minutes, the occluded ICA was recanalized with the remaining stenosis as severe as that seen on initial angiography (<xref ref-type="fig" rid="F2">Fig. 2C</xref>). We inserted a self-expandable carotid stent (SMART, 7 &#xD7; 80 mm Cordis, Warren, NJ, USA), and subsequent angiography showed no remaining stenosis (<xref ref-type="fig" rid="F2">Fig. 2D</xref>). A brain MRI performed 10 days after thrombolysis showed acute cerebral infarctions involving the right fronto-parietal and medial frontal cortex. Four weeks following thrombolysis, the patient's NIHSS score had improved to six.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Fibrinolysis by rt-PA heightens platelet activity and exposes clot-bound thrombin, facilitating rethrombosis via the cleavage of fibrinogen to fibrin.<xref ref-type="bibr" rid="B6">6</xref> In addition, high blood flow velocity due to remaining arterial stenosis may further activate platelet aggregation. Thus, a blockade of platelet-mediated thrombotic mechanisms appeared to be a rational approach to the management of this patient, as platelets seemed to play a key role in the rethrombosis. Highly effective inhibition of platelet activity can be achieved by the introduction of potent inhibitors of the GP IIb/IIIa receptor.</p>
      <p>It has been reported that GP IIb/IIIa receptor blockers can decrease the incidence of restenosis and ischemic complications after percutaneous transcoronary angioplasty.<xref ref-type="bibr" rid="B7">7</xref> Recently, GP IIb/IIIa receptor blockers were advocated as potentially promising agents for acute stroke therapy, and there were some case studies reporting the successful rescue use of GP IIb/IIIa receptor blocker in acute ischemic stroke.<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B10">10</xref> Tirofiban is a non-peptide tyrosine derivative that mimics the RGD integrin recognition sequence. It has a very short platelet-bound half-life and a relatively long plasma half-life, therefore providing an advantage when the rapid reversal of antiplatelet action is required such as in cases of high-risk hemorrhage or in combined use with thrombolytics. It has been reported that tirofiban produces a dose-dependent, dethrombotic effect on thrombosis and inhibits acute <italic>de novo</italic> stent thrombosis under high-shear flow conditions in an <italic>ex vivo</italic> canine arteriovenous shunt model.<xref ref-type="bibr" rid="B11">11</xref> Tirofiban is generally used intravenously in coronary artery disease, with a loading dose of 0.4 &#xB5;g/kg/min for 30 minutes and a subsequent infusion of 0.1 &#xB5;g/kg/min. We initially planned to use the standard intravenous loading dose (900 &#xB5;g) intra-arterially; however, after use of only 200 &#xB5;g intra-arterial tirofiban, the ICA was successfully recanalized. We speculate that intra-arterial drug delivery may reduce the dose of tirofiban required to dissolve the thrombus.</p>
      <p>This case demonstrates that a GP IIb/IIIa receptor blocker is effective for the recanalization of reoccluded arteries, especially in the presence of arterial stenosis. The dose of GP IIb/IIIa receptor blocker can be reduced by intra-arterial use, as compared with intravenous use and may be effective at preventing hemorrhagic complications, especially when used in combination with thrombolytics. Although this case showed promising results of intra-arterial tirofiban use, further studies are necessary to verify the effect of intra-arterial use of tirofiban and to determine its proper dose.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alexandrov</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Grotta</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator</article-title>
          <source>Neurology</source>
          <year>2002</year>
          <volume>59</volume>
          <fpage>862</fpage>
          <lpage>867</lpage>
          <pub-id pub-id-type="pmid">12297567</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qureshi</surname>
              <given-names>AI</given-names>
            </name>
            <name>
              <surname>Siddiqui</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Hanel</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Xavier</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Kirmani</surname>
              <given-names>JF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke</article-title>
          <source>AJNR Am J Neuroradiol</source>
          <year>2004</year>
          <volume>25</volume>
          <fpage>322</fpage>
          <lpage>328</lpage>
          <pub-id pub-id-type="pmid">14970040</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heo</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>KY</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>DI</given-names>
            </name>
          </person-group>
          <article-title>Immediate reocclusion following a successful thrombolysis in acute stroke: a pilot study</article-title>
          <source>Neurology</source>
          <year>2003</year>
          <volume>60</volume>
          <fpage>1684</fpage>
          <lpage>1687</lpage>
          <pub-id pub-id-type="pmid">12771267</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seitz</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Meisel</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Moll</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wittsack</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Junghans</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Siebler</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The effect of combined thrombolysis with rtPA and tirofiban on ischemic brain lesions</article-title>
          <source>Neurology</source>
          <year>2004</year>
          <volume>62</volume>
          <fpage>2110</fpage>
          <lpage>2112</lpage>
          <pub-id pub-id-type="pmid">15184627</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Straub</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Junghans</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Jovanovic</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Wittsack</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Seitz</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Siebler</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Systemic thrombolysis with recombinant tissue plasminogen activator and tirofiban in acute middle cerebral artery occlusion</article-title>
          <source>Stroke</source>
          <year>2004</year>
          <volume>35</volume>
          <fpage>705</fpage>
          <lpage>709</lpage>
          <pub-id pub-id-type="pmid">14752128</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>KY</given-names>
            </name>
            <name>
              <surname>Heo</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>Yoon</surname>
              <given-names>PH</given-names>
            </name>
          </person-group>
          <article-title>Rescue treatment with abciximab in acute ischemic stroke</article-title>
          <source>Neurology</source>
          <year>2001</year>
          <volume>56</volume>
          <fpage>1585</fpage>
          <lpage>1587</lpage>
          <pub-id pub-id-type="pmid">11402123</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <collab>The EPIC Investigators</collab>
          <article-title>Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty</article-title>
          <source>N Engl J Med</source>
          <year>1994</year>
          <volume>330</volume>
          <fpage>956</fpage>
          <lpage>961</lpage>
          <pub-id pub-id-type="pmid">8121459</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wallace</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Furlan</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Moliterno</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Stevens</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>Masaryk</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Perl</surname>
              <given-names>J</given-names>
              <suffix>2nd</suffix>
            </name>
          </person-group>
          <article-title>Basilar artery rethrombosis: successful treatment with platelet glycoprotein IIB/IIA receptor inhibitor</article-title>
          <source>AJNR Am J Neuroradiol</source>
          <year>1997</year>
          <volume>18</volume>
          <fpage>1257</fpage>
          <lpage>1260</lpage>
          <pub-id pub-id-type="pmid">9282851</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liebeskind</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Pollard</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>ED</given-names>
            </name>
            <name>
              <surname>Cucchiara</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>McGarvey</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Hurst</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>Vertebrobasilar thrombolysis with intravenous tirofiban: case report</article-title>
          <source>J Thromb Thrombolysis</source>
          <year>2002</year>
          <volume>13</volume>
          <fpage>81</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="pmid">12101384</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ho</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Chui</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Cheung</surname>
              <given-names>RT</given-names>
            </name>
          </person-group>
          <article-title>Intracarotid abciximab injection to abort impending ischemic stroke during carotid angioplasty</article-title>
          <source>Cerebrovasc Dis</source>
          <year>2001</year>
          <volume>11</volume>
          <fpage>300</fpage>
          <lpage>304</lpage>
          <pub-id pub-id-type="pmid">11385208</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rukshin</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Azarbal</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Finkelstein</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Cercek</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Tsang</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effects of GP IIb/IIIa receptor inhibitor tirofiban (aggrastat) in <italic>ex vivo</italic> canine arteriovenous shunt model of stent thrombosis</article-title>
          <source>J Cardiovasc Pharmacol</source>
          <year>2003</year>
          <volume>41</volume>
          <fpage>615</fpage>
          <lpage>624</lpage>
          <pub-id pub-id-type="pmid">12658064</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" position="float">
      <label>Fig. 1</label>
      <caption>
        <p>Initial brain CT angiography shows bilateral internal carotid artery occlusions.</p>
      </caption>
      <graphic xlink:href="ymj-49-857-g001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Fig. 2</label>
      <caption>
        <p>Serial cerebral angiography. (A) The initial angiography reveals severe stenosis of the right cervical ICA. (B) Reocclusion of the right ICA 20 minutes after initial angiography. (C) After intra-arterial tirofiban infusion, the occluded right ICA is recanalized and severe stenosis remains. (D) Final angiography after carotid stent insertion shows no stenosis of the right ICA. ICA, internal carotid artery.</p>
      </caption>
      <graphic xlink:href="ymj-49-857-g002"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
